More articles by Brian Boettcher Proposal for a Tirzepatide-LLF580 Fusion Protein Apr 16, 2023 Proposal for a Tirzepatide-LLF580 Fusion Protein A new proposal published on ResearchGate is an extension of my prior article (Boettcher, 2023) updating the gastric Gastric Bypass Surgery Mimetic Update Mar 21, 2023 Gastric Bypass Surgery Mimetic Update Fc-FGF21 fusion protein analog with an additional stabilizing disulfide linkage may be suitable for once a month dosing in humans Feb 21, 2020 Fc-FGF21 fusion protein analog with an additional stabilizing disulfide linkage may be suitable for once a month dosing in humans A new patent application (Goldfine and Yi 2019) provides pharmacokinetic data from cynomolgus monkeys that may support Pancreatitis is an FGF21-deficient state that is corrected by replacement therapy Jan 11, 2020 Pancreatitis is an FGF21-deficient state that is corrected by replacement therapy A new report in Science Translational Medicine (January 8, 2020) from the David Mangelsdorf and Steven Kliewer lab Novartis to Initiate Phase 3 Clinical Trial with TQJ230 Targeting Lipoprotein(a) Dec 6, 2019 Novartis to Initiate Phase 3 Clinical Trial with TQJ230 Targeting Lipoprotein(a) The first project that I helped initiate at a Novartis precursor company (Sandoz) over 25 years ago targeted Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity Sep 5, 2019 Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity A new report published in the Journal of the American Medical Association indicates that metabolic surgeries (mainly Six Approaches to Mimic Gastric Bypass Surgery Sep 17, 2018 Six Approaches to Mimic Gastric Bypass Surgery For details on these approaches see Boettcher, B
However, LR3 IGF-1 has a low affinity for IGF binding proteins (IGFBP), thus reducing physiologic regulation of IGF-1 bioavailability
What matters is consistency, same day, every week, without skipping
Animal studies have raised concerns including smaller fetuses, delayed bone development, skeletal changes and pregnancy loss, especially when mothers lose a significant amount of weight during early fetal development
Some patients benefit from working with a registered dietitian familiar with GLP-1 medications, who can help adjust eating patterns as appetite naturally decreases
&srotate=0)
